Cargando…
Substantial fibrin amyloidogenesis in type 2 diabetes assessed using amyloid-selective fluorescent stains
BACKGROUND: We have previously shown that many chronic, inflammatory diseases are accompanied, and possibly partly caused or exacerbated, by various coagulopathies, manifested as anomalous clots in the form of ‘dense matted deposits’. More recently, we have shown that these clots can be amyloid in n...
Autores principales: | Pretorius, Etheresia, Page, Martin J., Engelbrecht, Lize, Ellis, Graham C., Kell, Douglas B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668975/ https://www.ncbi.nlm.nih.gov/pubmed/29096623 http://dx.doi.org/10.1186/s12933-017-0624-5 |
Ejemplares similares
-
Serum amyloid A binds to fibrin(ogen), promoting fibrin amyloid formation
por: Page, Martin J., et al.
Publicado: (2019) -
Both lipopolysaccharide and lipoteichoic acids potently induce anomalous fibrin amyloid formation: assessment with novel Amytracker™ stains(†)
por: Pretorius, Etheresia, et al.
Publicado: (2018) -
Lipopolysaccharide-binding protein (LBP) can reverse the amyloid state of fibrin seen or induced in Parkinson's disease
por: Pretorius, Etheresia, et al.
Publicado: (2018) -
The Potential of LPS-Binding Protein to Reverse Amyloid Formation in Plasma Fibrin of Individuals With Alzheimer-Type Dementia
por: Pretorius, Etheresia, et al.
Publicado: (2018) -
Lipopolysaccharide-binding protein (LBP) reverses the amyloid state of fibrin seen in plasma of type 2 diabetics with cardiovascular co-morbidities
por: Pretorius, Etheresia, et al.
Publicado: (2017)